Collegium Pharmaceutical (COLL) EBIAT: 2016-2025
Historic EBIAT for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $31.5 million.
- Collegium Pharmaceutical's EBIAT rose 237.51% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.4 million, marking a year-over-year decrease of 34.03%. This contributed to the annual value of $69.2 million for FY2024, which is 43.68% up from last year.
- According to the latest figures from Q3 2025, Collegium Pharmaceutical's EBIAT is $31.5 million, which was up 162.93% from $12.0 million recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's EBIAT registered a high of $72.8 million during Q2 2021, and its lowest value of -$25.0 million during Q4 2021.
- Over the past 3 years, Collegium Pharmaceutical's median EBIAT value was $13.0 million (recorded in 2023), while the average stood at $14.8 million.
- As far as peak fluctuations go, Collegium Pharmaceutical's EBIAT tumbled by 459.79% in 2021, and later surged by 4,415.10% in 2023.
- Collegium Pharmaceutical's EBIAT (Quarterly) stood at -$25.0 million in 2021, then surged by 71.24% to -$7.2 million in 2022, then spiked by 543.67% to $31.9 million in 2023, then slumped by 60.75% to $12.5 million in 2024, then soared by 237.51% to $31.5 million in 2025.
- Its EBIAT stands at $31.5 million for Q3 2025, versus $12.0 million for Q2 2025 and $2.4 million for Q1 2025.